![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 36, 26483-26490, September 8, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1


2
From the
Department of Pharmacology and Cancer Biology and
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710 and the ¶Department of Pathology, Medical College of Georgia, Augusta, Georgia 30912
Many studies have suggested a role for the members of the G12 family of heterotrimeric G proteins (G
12 and G
13) in oncogenesis and tumor cell growth. However, few studies have examined G12 signaling in actual human cancers. In this study, we examined the role of G12 signaling in prostate cancer. We found that expression of the G12 proteins is significantly elevated in prostate cancer. Interestingly, expression of the activated forms of G
12 or G
13 in the PC3 and DU145 prostate cancer cell lines did not promote cancer cell growth. Instead, expression of the activated forms of G
12 or G
13 in these cell lines induced cell invasion through the activation of the RhoA family of G proteins. Furthermore, inhibition of G12 signaling by expression of the RGS domain of the p115-Rho-specific guanine nucleotide exchange factor (p115-RGS) in the PC3 and DU145 cell lines did not reduce cancer cell growth. However, inhibition of G12 signaling with p115-RGS in these cell lines blocked thrombin- and thromboxane A2-stimulated cell invasion. These observations identify the G12 family proteins as important regulators of prostate cancer invasion and suggest that these proteins may be targeted to limit invasion- and metastasis-induced prostate cancer patient mortality.
Received for publication, May 8, 2006
* This work was supported by National Institutes of Health Grants CA100869 (to P. J. C.) and AG17952 and DK60917 (to Y. D.), Department of Defense Grant DAMD17-03-1-0691 (to T. A. F.), and the Morris Cancer Center (to P. J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.
1 Supported by the Duke University Medical School Alumni Scholarship.
2 To whom correspondence should be addressed: Box 3813, Duke University Medical Center, Durham, NC 27710-3813. Tel.: 919-613-8613; Fax: 919-613-8642; E-mail: casey006{at}mc.duke.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
O. Moussa, A. W. Ashton, M. Fraig, E. Garrett-Mayer, M. A. Ghoneim, P. V. Halushka, and D. K. Watson Novel Role of Thromboxane Receptors {beta} Isoform in Bladder Cancer Pathogenesis Cancer Res., June 1, 2008; 68(11): 4097 - 4104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nie, Y. Guo, D. Yang, Y. Tang, Y. Chen, M.-T. Wang, A. Zacharek, Y. Qiao, M. Che, and K. V. Honn Thromboxane A2 Receptors in Prostate Carcinoma: Expression and Its Role in Regulating Cell Motility via Small GTPase Rho Cancer Res., January 1, 2008; 68(1): 115 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Goulimari, H. Knieling, U. Engel, and R. Grosse LARG and mDia1 Link G{alpha}12/13 to Cell Polarity and Microtubule Dynamics Mol. Biol. Cell, January 1, 2008; 19(1): 30 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Otto, P. Kelly, S.-T. Chiou, and J. D. York Alterations in an inositol phosphate code through synergistic activation of a G protein and inositol phosphate kinases PNAS, October 2, 2007; 104(40): 15653 - 15658. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Yanamadala, H. Negoro, L. Gunaratnam, T. Kong, and B. M. Denker G{alpha}12 Stimulates Apoptosis in Epithelial Cells through JNK1-mediated Bcl-2 Degradation and Up-regulation of I{kappa}B{alpha} J. Biol. Chem., August 17, 2007; 282(33): 24352 - 24363. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Evelyn, S. M. Wade, Q. Wang, M. Wu, J. A. Iniguez-Lluhi, S. D. Merajver, and R. R. Neubig CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling Mol. Cancer Ther., August 1, 2007; 6(8): 2249 - 2260. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |